[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f5NyAw7WGrY7EUVsrJsZiTbcvaolA18YpBXrQW_S7dHE":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":24,"type":25},[],"2024-04-25 12:55:12",140186952,[8,9,10,11],"正常血清中的单一组分,随抗原刺激而血清含量升高","由 30 多种蛋白组成的多分子系统,具有酶的活性和自我调节作用","正常血清中的单一组分,可被抗原-抗体复合物激活","存在正常血清中,是一组对热稳定的组分",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},10,"2032656ab982e87fc9fb33f55e446b3d","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F48eba3395437dd881b1b9275a0ad1028.png","医学免疫学–2022临床2班","exam_116924259","补体--习题","补体系统是",[21,26,35,44,53,62,71,80,89,100],{"answer":22,"createTime":5,"id":6,"options":23,"question":19,"source":24,"type":25},[],[8,9,10,11],"v1",0,{"answer":27,"createTime":5,"id":28,"options":29,"question":34,"source":24,"type":25},[],140186953,[30,31,32,33],"细菌脂多糖","病原体甘露糖残基","FCN","免疫复合物","补体替代(旁路)途径的"激活物"是",{"answer":36,"createTime":5,"id":37,"options":38,"question":43,"source":24,"type":25},[],140186954,[39,40,41,42],"IgM","IgG","IgA","IgE","经典途径中,激活补体能力最强的免疫球蛋白是",{"answer":45,"createTime":5,"id":46,"options":47,"question":52,"source":24,"type":25},[],140186955,[48,49,50,51],"C3b 和 C4b","C3a 和 C5a","C2b 和 C4b","C3b 和 C5b","具有调理作用的补体活性片段是",{"answer":54,"createTime":5,"id":55,"options":56,"question":61,"source":24,"type":25},[],140186956,[57,58,59,60],"IgG1、IgG2、IgD、IgM","IgG1、IgG2、IgG3、IgA","IgG1、IgG2、IgG3、IgM","IgG2、IgG3、IgG4、IgM","C1q 能与哪些 Ig 的 Fc 段结合",{"answer":63,"createTime":5,"id":64,"options":65,"question":70,"source":24,"type":25},[],140186957,[66,67,68,69],"IgD 和 IgM","IgM 和 IgE","IgA 和 IgG","IgG 和 IgM","与抗原结合后,可激活补体经典途径的Ig是",{"answer":72,"createTime":5,"id":73,"options":74,"question":79,"source":24,"type":25},[],140186958,[75,76,77,78],"膜攻击复合物的形成及其溶解细胞效应相同","激活物质相同","C3 转化酶的组成相同","参与的补体成分相同","三条补体激活途径的共同点是",{"answer":81,"createTime":5,"id":82,"options":83,"question":88,"source":24,"type":25},[],140186959,[84,85,86,87],"C4b2a","C4b2a3b","C3bnBb","C3bBb","补体经典激活途径中形成的C3转化酶是",{"answer":90,"createTime":5,"id":91,"options":92,"question":98,"source":24,"type":99},[],140186960,[93,94,95,96,97],"补体成分大多数以非活性的酶前体存在于血清中","补体系统激活的三条途径均是酶的级联反应","补体系统在非特异性免疫和特异性免疫中发挥作用","激活的补体具有生理作用和病理作用","补体系统的激活具有放大效应","关于补体系统的叙述下列哪些是正确的",1,{"answer":101,"createTime":5,"id":102,"options":103,"question":107,"source":24,"type":99},[],140186961,[39,104,105,106,30],"酵母多糖","凝聚的IgA","葡聚糖","能通过旁路途径激活补体的物质包括"]